Literature DB >> 22368938

[Distribution of Buruli ulcer in the Zè district of Benin].

G Sopoh1, A Victoire, R C Johnson, Y Barogui, A Dossou, T S Van der Werf, Y Stienstra, M Makoutodé, M Boko.   

Abstract

The goals of this cross-sectional study conducted in the Zè district of Benin were to determine the overall distribution and prevalence of Buruli ulcer (BU) and to identify environmental and behavioral risk factors. A total of 425 current or previous BU patients from the study district were included. Data was obtained by direct observation, semi-structured interviews, and document review. The main findings can be summarized as follows. The overall prevalence of BU in the Zè district in 2006 was 52 cases per 10000 inhabitants. The prevalence of current and previous cases was 28.1 and 23.9 per 10 000 inhabitants respectively. The distribution of BU within the district was highly variable from one subdistrict to another and from one village to another within the same subdistrict. The subdistricts showing the highest and lowest endemicity were Djigbé with 265 cases per 10 000 inhabitants and Koundokpoé with 3 cases per 10 000 inhabitants respectively. Proximity of the hamlets to water bodies was a risk factor for the disease.

Entities:  

Mesh:

Year:  2010        PMID: 22368938

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  2 in total

1.  Buruli ulcer prevalence and altitude, Benin.

Authors:  Ghislain Emmanuel Sopoh; Roch Christian Johnson; Séverin Yehouénou Anagonou; Yves Thierry Barogui; Ange Dodji Dossou; Jean Gabin Houézo; Delphin Mavingha Phanzu; Brice Hughes Tente; Wayne M Meyers; Françoise Portaels
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

2.  Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus.

Authors:  Hope Simpson; Kebede Deribe; Earnest Njih Tabah; Adebayo Peters; Issaka Maman; Michael Frimpong; Edwin Ampadu; Richard Phillips; Paul Saunderson; Rachel L Pullan; Jorge Cano
Journal:  Lancet Glob Health       Date:  2019-07       Impact factor: 26.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.